Abstract
Breast cancer, a heterogeneous malignancy, is the most common cancer among women globally, with diverse histological types and pathomorphological features influencing prognosis and treatment. This article explores the types and pathomorphological characteristics of breast cancer, focusing on invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), ductal carcinoma in situ (DCIS), and rare subtypes, alongside their histopathological patterns, molecular profiles, and clinical implications. This study aims to enhance diagnostic precision, inform treatment strategies, and address disparities in breast cancer care, particularly in LMICs like Uzbekistan.
References
[1] Healthcare Finance Review. (2025). Economic burden of breast cancer. Retrieved from https://www.hcfr.org/reports/breast-cancer-2025
[2] JAMA Oncology. (2025). Molecular subtypes and prognosis in breast cancer. JAMA Oncology, 11(5), 456–465. https://doi.org/10.1001/jamaoncol.2025.8901
[3] Journal of Breast Cancer. (2025). Risk factors and outcomes in breast cancer. Journal of Breast Cancer, 28(2), 201–210. https://doi.org/10.4048/jbc.2025.28.e15
4] Journal of Clinical Oncology. (2025). Breast cancer epidemiology in Uzbekistan. Journal of Clinical Oncology, 43(6), 678–687. https://doi.org/10.1200/JCO.2025.43.6.678
[5] Journal of Clinical Pathology. (2025). Molecular mechanisms in breast cancer pathology. Journal of Clinical Pathology, 78(7), 567–576. https://doi.org/10.1136/jclinpath-2025-210345
[6] Journal of Pathology. (2025). Pathomorphological features of breast cancer subtypes. Journal of Pathology, 264(4), 523–532. https://doi.org/10.1002/path.6678
